It's More Fun with Goldens
March 26, 2019 – Golden Retriever Lifetime Study participant Julie Cuenod talks about how losing her dog Teddie inspired her to enroll her dogs Ellie and Tate.
Displaying 121 - 130 of 441 results
Beating the Cancer Odds
June 6, 2019 – Chase Manhattan (the cream colored dachshund, not the bank) beat the odds and survived hemangiosarcoma. Read about her amazing story of survival.
Taking Stock of the Golden Retriever Lifetime Study
July 24, 2023 – As the Golden Retriever Lifetime Study turns 11 years old, it’s a great time for some updates on our Study cohort as well as additional Study-related research initiatives underway.
A Pilot Study to Overcoming Chemoresistance in Canine Osteosarcoma
SUMMARY: Researchers will study chemoresistance in osteosarcoma cell lines to learn more about why this occurs and how it could be overcome. THE PROBLEM: Osteosarcoma is a highly aggressive bone...
Finding a New Purpose After Cancer
April 27, 2020 – Meet Marejka Shaevitz, veterinarian and cancer survivor, and learn how her experience led her to become a veterinary oncologist.
Morris Animal Foundation Partners With V Foundation – $2 Million Raised for Golden Retriever Lifetime Study
November 6, 2019 – With a challenge match of $1
Dog Breeds With Increased Cancer Risk
June 21, 2016 – What breeds top the list when it comes to cancer risk? Check out the answer and see if your dog could be at risk for this serious disease.
How Does Cancer Affect Wildlife?
May 25, 2017 – Cancer in wildlife poses unique challenges when it comes to treatment. Learn more about how the Foundation is working to solve this difficult problem.
Evaluating a Promising Cancer Drug
Researchers will evaluate the potential of a novel drug derived from the feverfew plant to treat rapidly fatal canine cancers.
Strange Bedfellows: Omega-3 Fatty Acid Supplements and Hypothyroidism Both Linked to Decreased Risk of T-zone Lymphoma in Dogs
April 2, 2019 – Dogs that receive omega-3 fatty acid supplements or have hypothyroidism may be less likely to develop T-zone lymphoma.